scispace - formally typeset
D

Drake S. Eggleston

Researcher at GlaxoSmithKline

Publications -  133
Citations -  4236

Drake S. Eggleston is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Crystal structure & Ring (chemistry). The author has an hindex of 28, co-authored 133 publications receiving 3996 citations. Previous affiliations of Drake S. Eggleston include Smith, Kline & French & Laboratory of Molecular Biology.

Papers
More filters
Journal ArticleDOI

Facile biocatalytic reduction of the carbon–carbon double bond of 5-benzylidenethiazolidine-2,4-diones. Synthesis of (±)-5-(4-{2-[methyl(2-pyridyl)amino]ethoxy}benzyl)thiazolidine-2,4-dione (BRL 49653), its (R)-(+)-enantiomer and analogues

TL;DR: A novel biotransformation system for the reduction of carbon-carbon double bonds in 5-benzylidenethiazolidine-2, 4-diones, using whole cells of red yeasts is described, which are of potential use in the treatment of non-insulin dependent diabetes mellitus.
Journal ArticleDOI

Guanidyl-carboxylate interactions: crystal structures of arginine dipeptides*

TL;DR: The crystal structures of the hydrated dipeptides larginyl-l-aspartic acid and l-arginyl l-glutamic acid have been determined from three-dimensional X-ray diffraction data as mentioned in this paper.
Journal ArticleDOI

Synthetic analogues of SB-219383. Novel C-glycosyl peptides as inhibitors of tyrosyl tRNA synthetase.

TL;DR: Novel inhibitors of bacterial tyrosyl tRNA synthetase have been synthesised in which the cyclic hydroxylamine moiety of SB-219383 is replaced by C-pyranosyl derivatives.
Journal ArticleDOI

Substituent effects on aromatic interactions in the solid state

TL;DR: A systematic series of structural studies has led to an understanding of how to use hydrogen bonding and steric interactions to control two aromatic rings to interact in a well-defined and predictable manner in the solid state as mentioned in this paper.